Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Submitted by
admin
on June 4, 2014 - 3:20pm
Source:
Yahoo/Benzinga
News Tags:
ASCO
cancer
Imbruvica
JNJ
Eli Lilly
Cyramza
Headline:
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Do Not Allow Advertisers to Use My Personal information
